Long‐term patient monitoring for clozapine‐induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?

Kang, Byung‐Jo; Cho, Man‐Je; Oh, Jung‐Tae; Lee, Yanghyun; Chae, Beang‐Jin; Ko, Jae‐Wook

doi:10.1002/hup.779

Public

Long‐term patient monitoring for clozapine‐induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?

Published in Human Psychopharmacology Clinical and Experimental • Jul 19, 2006

Authors:

Byung‐Jo Kang

Man‐Je Cho

Jung‐Tae Oh

Abstract

OBJECTIVES: This study documents the incidences of agranulocytosis and neutropenia, and the patterns of incidence of the side effects of long-term clozapine treatment in order to determine an appropriate time to stop the Clozaril Patient Monitoring System (CPMS). METHODS: Hematological, demographic,...

Subject

Neutropenia

Clozapine

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!